Research/ Academia/ Activities
Effects of NMN! Potential to contribute to the ...
Mirai Lab Bioscience Corporation (Headquarters: Chuo-ku, Tokyo; CEO: Megumi Tanaka) will present the results obtained through collaborative research with Professor Toru Kimura from the Joint Faculty of Veterinary Medicine at...
Effects of NMN! Potential to contribute to the ...
Mirai Lab Bioscience Corporation (Headquarters: Chuo-ku, Tokyo; CEO: Megumi Tanaka) will present the results obtained through collaborative research with Professor Toru Kimura from the Joint Faculty of Veterinary Medicine at...
Joined as a supporting member of the Japan Anti...
ミライラボバイオサイエンスは日本抗加齢協会の設立趣旨に賛同し、産学協同の精神のもと、ともに抗加齢医学の発展と人々の健康と生きがいの増進に貢献することを共に目指していくことになりましたのでお知らせいたします。 日本抗加齢協会の賛助会員に関してはこちら
Joined as a supporting member of the Japan Anti...
ミライラボバイオサイエンスは日本抗加齢協会の設立趣旨に賛同し、産学協同の精神のもと、ともに抗加齢医学の発展と人々の健康と生きがいの増進に貢献することを共に目指していくことになりましたのでお知らせいたします。 日本抗加齢協会の賛助会員に関してはこちら
Research program to elucidate the molecular bio...
Shinko Pharmaceutical Co., Ltd. (Headquarters: Chuo-ku, Tokyo; CEO: Megumi Tanaka) has launched a series of life science research programs focusing on the mechanism of action and effects of Nicotinamide Mononucleotide...
Research program to elucidate the molecular bio...
Shinko Pharmaceutical Co., Ltd. (Headquarters: Chuo-ku, Tokyo; CEO: Megumi Tanaka) has launched a series of life science research programs focusing on the mechanism of action and effects of Nicotinamide Mononucleotide...